Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People who have been referred to the Chronic Pain Unit at Hospital Universitario de Gran Canaria Dr. Negrín for ozone therapy as a symptomatic or palliative treatment, because standard treatments are unavailable, have not worked, or carry high risks or significant side effects
- People for whom doctors have determined that adding ozone treatment to their current treatment could provide a potential benefit
- People who have no medical reasons preventing them from receiving ozone treatment
- People who have signed and dated the required consent forms for both the compassionate ozone treatment and this specific study
Who may not be able to join:
- People under 18 years of age
- People with a psychiatric illness or personal circumstances that would make it difficult to follow the study requirements
- People who are unable to complete the questionnaires and measurement scales used in the study
- People who are medically unstable or have a severe illness that is not under control
- People with cancer that is not under control and requires chemotherapy
- People with a life expectancy of less than 6 months
- People who have a medical reason preventing them from attending scheduled treatments, or who are otherwise unable to attend
- People with a known allergy to ozone
- People who are pregnant at the time of enrolment (specifically for systemic ozone therapy)
- People with a condition called haemochromatosis (a disorder involving excess iron in the body) (specifically for systemic ozone therapy)
- People with a significant, known deficiency of an enzyme called glucose-6-phosphate dehydrogenase — this includes conditions known as favism or acute haemolytic anaemia (specifically for systemic ozone therapy)
- People who do not meet all of the inclusion criteria listed above
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Bernardino Clavo, MD, PhyD, Dr. Negrín University Hospital, Las Palmas, Spain
Phone: (34)928449278
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from Baseline in the health-related quality of life by the "5-level, 5-dimension EuroQol" (EQ-5D-5L) questionnaire (at the end of ozone therapy)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.